logo
Share SHARE
FONT-SIZE Plus   Neg

Mindray Medical Q4 Profit Rises - Quick Facts

Mindray Medical International Limited (MR) announced that its fourth quarter 2011 net income attributable to the Company was $46.8 million up from $41.0 million in the fourth quarter of 2010. Earnings per share were $0.40, up from $0.35 in the fourth quarter of 2010.

Non-GAAP net income increased 14.2% to $51.8 million from $45.4 million in the fourth quarter of 2010. Non-GAAP earnings per share were $0.44, compared to $0.38 in the fourth quarter of 2010.

Net revenues were $264.1 million for the fourth quarter of 2011, a 25.2% increase from $211.0 million in the fourth quarter of 2010.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $249.17 million for the quarter. Analysts' estimates typically exclude special items.

Mindray's board has declared a cash dividend on its ordinary shares of $0.40 per share, based on the company's net income for the full year 2011. The cash dividend will be payable on or around April 10, 2012, to shareholders of record as of March 9, 2012.

The company expects its full year 2012 net revenues to grow at least 18% over its full year 2011 net revenues. The company also expects its full year 2012 non-GAAP net income to grow at least 13% over its non-GAAP net income for full year 2011. Analysts expect the company to report earnings of $1.69 per share on revenues of $1.03 billion for foscal 2012.

The company expects its capital expenditure for 2012 to be around $90 million.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Seafood lovers must now be prepared to dole out more cash than before for salmon. The price of salmon has surged globally and is now at historic highs amid acute outbreaks of sea lice. According to data from the Nasdaq Salmon Index, the price of salmon has risen by more than 15 percent in the last three months. Health-food restaurant chain Freshii Inc. has increased the price range for its initial public offering in Canada. Freshii has raised the price range for its IPO to C$10 to C$11.50 per share from the prior range of C$8.50 to C$10.0 per share, BNN reported. Drug major Johnson & Johnson Tuesday said it expects higher earnings and sales for its fiscal 2017, which are below market estimates. The company also reported solid fourth-quarter results, with adjusted earnings above market estimates, while sales missed their view, despite a growth. In pre-market activity on the NYSE, Johnson & Johnson shares were losing 1.68 percent.
comments powered by Disqus
Follow RTT